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http:WHAT THIS PAPER ADDS
This article describes a new method of StO2 foot-mapping for the assessment of peripheral tissue perfusion in
critical limb ischemia, and presents a new concept, namely the “real angiosome,” which is compared with the
conventional angiosome model. StO2 foot-mapping can non-invasively detect the actual distribution of pe-
ripheral tissue perfusion (real angiosome) in the CLI patient’s foot more appropriately than the assessment
based on angiography and the angiosome model.Objectives: The “tissue oxygen saturation (StO2) foot-mapping” method was developed using a non-invasive
near-infrared tissue oximeter monitor to classify the foot regions as ischemic and non-ischemic areas. The
purpose of this study was to evaluate StO2 foot-mapping as a reliable method to detect ischemic areas in the feet
of patients with critical limb ischemia (CLI), and to compare the results with assessments from the angiosome
model.
Methods: The foot areas of 20 CLI patients and 20 healthy controls were classiﬁed into four regions: (1)
0  StO2 < 30%, (2) 30  StO2 < 50%, (3) 50  StO2 < 70%, and (4) 70  StO2  100% to perform StO2 foot-
mapping. Each area occupancy rate was compared between the two groups, and the threshold StO2 value for
detecting ischemia was set. Next, the locations of ulcers (in 16 patients) were compared to the predicted
ischemic regions by the StO2 foot-mapping and by the angiosome model and angiography.
Results: In regions (1) and (2) (StO2 < 50%), the area occupancy rate was signiﬁcantly higher in the CLI group and
almost zero in the control group, so that the threshold StO2 value for detecting ischemia was set at 50%. The
locations of ulcers were compatible with StO2 foot-mapping in 87.5% of the cases (14/16), while they were
compatible with the assessment from the angiosome model in 68.8% of the cases (11/16).
Conclusions: This study suggests that StO2 foot-mapping can successfully and non-invasively detect ischemic
areas in the peripheral tissue of the foot, and also more appropriately than the assessment provided by the
angiosome model. StO2 foot-mapping can be used to evaluate the real angiosome: the real distribution of the
peripheral tissue perfusion in the CLI patient’s foot, which is determined by the peripheral microvascular blood
ﬂow, rather than the main arterial blood ﬂow.
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Peripheral tissue perfusionINTRODUCTION
For the appropriate treatment of critical limb ischemia (CLI),
it is necessary to evaluate peripheral tissue perfusion and
understand the distribution of ischemic and non-ischemic
areas in a CLI patient’s foot.
Recently, the angiosome concept has been an essential
idea for both the evaluation of tissue perfusion in CLI pa-
tients’ feet and in the treatment of CLI.1e5 The angiosome isrresponding author. Y. Kagaya, Department of Plastic and Recon-
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//dx.doi.org/10.1016/j.ejvs.2013.11.011a model of ﬁve or six distinct three-dimensional blocks of
tissue fed by three main source arteries and their branches
to the foot and ankle. Angiography can visualize the main
arterial blood ﬂow and the branches, but cannot visualize
the microvascular blood ﬂow that directly feeds peripheral
tissue, so the angiosome model has been used to predict
the peripheral tissue perfusion from the main arterial blood
ﬂow. However, discrepancies sometimes occur between the
predicted ischemic region from angiography using the
angiosome model and the actual ulcerated region in a CLI
patient’s foot.
We developed a new method of “tissue oxygen satura-
tion (StO2) foot-mapping” utilizing a near-infrared tissue
oximeter monitor to non-invasively evaluate the peripheral
tissue perfusion and detect the ischemic areas in the entire
Figure 1. The near-infrared tissue oximeter monitor, the OXY-2. (A)
The appearance of the OXY-2: the device consists of a monitor and
a sensor probe. (B) Measurement of StO2. The sensor probe is
directly placed on the skin surface, enabling the non-invasive
measurement. (C) The screen of the OXY-2: real-time StO2 values
(1) are shown on the screen. A continuous record of the StO2 (2) is
also shown on the same screen.
434 Y. Kagaya et al.foot of a CLI patient. We measure the StO2 of many points
on the foot using the near-infrared tissue oximeter monitor,
and make a map by classifying the foot regions into low and
high StO2 areas.
In order to evaluate the appropriateness of StO2 foot-
mapping as a reliable method to detect ischemic areas
in CLI, the results of StO2 foot-mapping were compared
for CLI patients and healthy controls. Furthermore, in
order to assess the validity of StO2 foot-mapping to locate
ischemic regions in CLI patients’ feet, the locations of
ulcers in the feet were compared with the predicted
ischemic regions using StO2 foot-mapping and using the
angiosome model.MATERIALS AND METHODS
Subjects
We performed a prospective study on 20 CLI patients (20
limbs) with chronic symptomatic peripheral arterial disease
(PAD) in Rutherford clinical categories 4/5/6 (ischemic rest
pain or ischemic ulceration) prior to revascularization, be-
tween January 2012 and September 2012. There were 14
males and six females, with a mean age of 71.2  10.1 years
(55e88 years). There were four Rutherford 4, 13 Rutherford
5 and three Rutherford 6 cases. Co-morbidity included ninediabetics on insulin and 15 with chronic kidney disease on
hemodialysis.
Angiography was carried out on all CLI patients within
6.40  5.72 days (0e21 days) after StO2 measurement, and
revascularization therapies were performed on all patients
(endovascular therapies in 18 cases and distal bypass op-
erations in 2 cases).
In contrast, 20 healthy volunteers (20 limbs; 5 males, 15
females) with no ischemic symptoms and no past history of
PAD, with a mean age of 32.5  6.88 years (24e52 years),
were included as the control group. The dorsalis pedis ar-
tery and posterior tibial artery (PTA) pulses were checked in
order to conﬁrm normal circulation.
The study was conducted in accordance with the Decla-
ration of Helsinki on investigations in humans and was
approved by the institutional ethics committees at the
participating institutions. Informed consent was obtained
from all patients and volunteers.
StO2 measuring device
The near-infrared tissue oximeter monitor, OXY-2 (ViOptix
Inc., Fremont, CA, USA), was used to measure the StO2
(Fig. 1). The OXY-2 is an optical measuring device using near-
infrared rays to non-invasively measure the oxygen satura-
tion of hemoglobin in soft tissue, which is located under the
sensor probe. The StO2 can be measured in real time and
recoded continuously by radiating near-infrared rays at two
wavelengths (830 nm and 690 nm) that are speciﬁcally
absorbed by oxyhemoglobin (HbO2) and deoxyhemoglobin
(Hb), respectively, up to a depth of 0e10 mm, and by
sensing diffuse light with four optical sensors inside the
sensor probe. The StO2 is the percentage of saturated he-
moglobin (StO2 (%) ¼ 100  HbO2/(HbO2 þ Hb)). StO2
values can be measured within 10 seconds per point, by
applying a sensor probe on the skin surface, while another
approximately 10 seconds are required to stabilize the
measurement values. Once the measurement values are
obtained, the sensor probe can immediately be moved to
the next measurement position, making speedy measure-
ment possible.
StO2 foot-mapping
In order to assess the StO2 values of the entire foot, the
boundary values of StO2 were set to 30%, 50%, and 70%,
and about 60 points of StO2 on the foot surface were
measured. After measuring the StO2, the StO2 value was
classiﬁed as, (1) 0  StO2 < 30%, (2) 30  StO2 < 50%, (3)
50  StO2 < 70%, (4) 70  StO2  100%, and that point
on the foot was marked (four types of mark had been
selected before the examination). In order to be able to
rapidly perform the measurements, it was sometimes
necessary to measure several points consecutively, and if
the adjacent points were classiﬁed in the same StO2 range,
a single mark was made in the region. In the boundary
region detailed measurements were made to determine
its precise position. After all the measurements had been
carried out, boundary lines were drawn according to the
European Journal of Vascular and Endovascular Surgery Volume 47 Issue 4 p. 433e441 April/2014 435markings of the four StO2 value areas to complete a StO2
foot-map (Fig. 2). After ﬁnishing the mapping, some
markings were erased to make the map easier to see. The
number of measurement points per patient varied ac-
cording to the complexity of the peripheral tissue perfu-
sion, but the average number of measurements was
approximately 60 per foot, and the average time required
for each foot was approximately 15 minutes.
The mapped foot was photographed with a digital cam-
era from two directions (dorsal and plantar sides of the
foot) for recording. With respect to the scope of mapping,
the dorsal region included the area from the meta-
carpophalangeal (MP) joint to the distal edge of the medial
and lateral malleolus, excluding the toes, while the planter
regions included the area from the MP joint to the calcaneal
region, excluding the toes. Measurement in the toes was
excluded because the proximity of the bones to the skin
made accurate measurement impossible.
The photographs were processed, and the four territories
from (1) to (4) were classiﬁed by color, using the Photoshop
software program (Adobe Systems Inc., San Jose, CA, USA)
in a bmp ﬁle format. The areas of the four territories wereFigure 2. Examples of StO2 foot-mapping. StO2 foot-maps of a patient w
directly recording with a pen onto the foot skin, with boundary StO2 v
classiﬁed by color, wherein (1) (0  StO2 < 30%) was black, (2) (30 
(70  StO2  100%) was red. (A) The CLI patient: area (1) (black) occu
area (2) (gray) occupancy rate of the territory was 32.4% (dorsal), and
3.7% (dorsal) and 7.2% (plantar), and area (4) (red) occupancy rate o
subject: area (1) (black) occupancy rate of the territory was 0% (dorsal)
0% (dorsal) and 0% (plantar), area (3) (pink) occupancy rate of the te
occupancy rate of the territory was 91.7% (dorsal) and 69.5% (plantarmeasured in pixel counts, to calculate the occupancy rate
deﬁned as the surface ratio between each region and the
entire area (Fig. 2).
The same physician in charge of the examination
measured the StO2 at outpatient clinics or in the hospital
wards. The subjects were supine during measurement,
with the foot horizontal after setting a soft cushion under
the lower leg in order to avoid putting pressure on the
heel.Items for assessment
Comparison of the StO2 foot-mapping between the CLI
group and the control group. The area occupancy rate of
each StO2 value region, (1) 0  StO2 < 30%, (2)
30  StO2 < 50%, (3) 50  StO2 < 70%, and (4)
70  StO2  100%, was compared between the CLI group
and the control group in order to evaluate the appropri-
ateness of StO2 foot-mapping as a method to detect
ischemic areas in a CLI patient’s foot.
Based on the results, the threshold StO2 value was set to
detect ischemic areas.ith critical limb ischemia (CLI) (A) and a control (B) were made by
alues of 30%, 50%, and 70%. Four territories from (1) to (4) were
StO2 < 50%) was gray, (3) (50  StO2 < 70%) was pink, and (4)
pancy rate of the territory was 63.9% (dorsal) and 47.8% (plantar),
45.1% (plantar), area (3) (pink) occupancy rate of the territory was
f the territory was 0% (dorsal) and 0% (plantar). (B) The control
and 0% (plantar), area (2) (gray) occupancy rate of the territory was
rritory was 8.3% (dorsal) and 30.5% (plantar), and area (4) (red)
).
436 Y. Kagaya et al.Comparison of the locations of ulcers and the predicted
ischemic regions by the StO2 foot-mapping and by the
angiosome model. The 16 patients with Rutherford 5/6
status, who had ischemic ulcers, were included in the
following evaluation.
The location of the ulcer compared with the results of StO2
foot-mapping. The area under the threshold StO2 value
(described above) was considered to be an ischemic area,
and foot regions of CLI patients were classiﬁed into low
StO2 (ischemic) and high StO2 (non-ischemic) areas. The
compatibility between the locations of ulcers and predicted
ischemic areas in StO2 foot-mapping was evaluated. The
ﬁndings were judged to be compatible if the ulcers were
surrounded mostly (more than 90%) by low StO2 areas.
The location of the ulcer compared with the results of the
angiography and the angiosome model. From the result of
angiography, the distribution of ischemic and non-ischemic
areas in a CLI patient’s foot was predicted utilizing the
angiosome model. There were minor differences in the
angiosome models used among past reports.1e5 We used
the angiosome shown in Fig. 3 to predict the ischemic and
non-ischemic areas in a CLI patient’s foot.
If the feeding arteries (anterior tibial artery, medial
plantar artery, lateral plantar artery, calcaneal branch of the
PTA, peroneal artery) were visualized to their ownFigure 3. The angiosomes of the foot and ankle. The six angiosomes of
tibial artery (ATA) becomes the dorsalis pedis artery supplying the dor
foot. The three main branches of the PTA supply distinct portions of the
the instep, and the lateral plantar artery to the lateral midfoot and the
artery. The ﬁrst toe may be supplied by the medial plantar artery via the
by the anterior circulation; as a result, the ﬁrst toe is classiﬁed as an in
artery supplies the lateral border of the ankle and heel.angiosome regions by angiography, even if by way of
collateral vessels, the angiosomes of these arteries were
predicted to be a non-ischemic.
The compatibility between the locations of the ulcers and
predicted ischemic areas from the angiosome model was
then evaluated.Statistical analysis
The differences between the CLI group and the control
group were reviewed using the ManneWhitney test.
RESULTS
StO2 foot-mapping was possible in all cases in both the CLI
group and the control group. Angiography was performed
on all CLI patients within an average of 6.40  5.72 days
(0e21 days) from the date of StO2 measurements.Comparison of StO2 foot-mapping between the CLI and
control groups
The total StO2 foot-mapping data (area occupancy rate) of
the dorsal and plantar regions are shown (Fig. 4A). The
average (dorsal and plantar) area occupancy rate of the four
regions, (1) 0%  StO2 < 30%, (2) 30%  StO2 < 50%, (3)
50%  StO2 < 70% and (4) 70%  StO2  100%, wasthe foot and ankle are fed by the three main arteries. The anterior
sum of the foot. The PTA feeds the toes, the sole, and heel of the
sole: the calcaneal branch to the heel, the medial plantar artery to
forefoot. The second to ﬁfth toes are supplied by the lateral plantar
deep branch, by the lateral plantar artery via the plantar arch, and
dependent angiosome supplied by the three arteries. The peroneal
Figure 4. Comparison of the area occupancy rate of the four classiﬁed StO2 value areas in StO2 foot-mapping between the critical limb
ischemia (CLI) patients and controls. (A) The distribution of the occupancy rates (%) of the four classiﬁed StO2 value areas in StO2 foot-
mapping of all the CLI patients and the controls. Area (1) (black) indicates the territory of 0%  StO2 < 30%, area (2) (gray) indicates the
territory of 30%  StO2 < 50%, area (3) (pink) indicates the territory of 50%  StO2 < 70%, area (4) (red) indicates the territory of
70%  StO2  100%. The dorsal and plantar data of each patient and control is shown together (upper line: dorsal, lower line: plantar). (B)
The average occupancy rate of the four classiﬁed StO2 value areas in the CLI group and the control group. The average occupancy rates of
dorsal and plantar sides of the four areas, (1) 0%  StO2 < 30%, (2) 30%  StO2 < 50%, (3) 50%  StO2 < 70%, and (4)
70%  StO2  100%, were compared between the CLI group and the control group. Signiﬁcant differences were found between the CLI
group and the control group in the areas of (1) (0%  StO2 < 30%), (2) (30%  StO2 < 50%), and (4) (70%  StO2  100%) (signiﬁcance
level < 1%).
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(Fig. 4B). Signiﬁcant differences were found in regions (1),
(2), and (4) (signiﬁcance level < 1%).
In regions (1) and (2) (StO2 < 50%), the area occupancy
rate was signiﬁcantly higher in the CLI group and almost
zero in the control group, so that the threshold StO2 value
was set at 50% for the detection of ischemic areas in a CLI
patient’s foot. The threshold StO2 value of 50% was used for
subsequent evaluations.Comparison of the locations of ulcers and the predicted
ischemic regions by the StO2 foot-mapping and by the
angiosome model
Using the threshold StO2 value of 50% (set above), the foot
regions of CLI patients were classiﬁed into low StO2
(StO2 < 50%, considered to be ischemic) and high StO2
(StO2  50%, considered to be non-ischemic) areas. In 14 of
the 16 patients (87.5%) the locations of ulcers were sur-
rounded mostly by low StO2 areas, which were judged to be
compatible cases (ulcer and StO2 foot-mapping). There were
11 cases among 16 patients (68.8%) in which the locations
of the ulcers were in angiosomes that were considered to
be ischemic, and were judged to be compatible cases (ulcer
and the angiosome model).Two representative cases are shown (Figs. 5 and 6). Fig. 5
shows a case where the locations of ulcers were compatible
with both the angiosome model and StO2 foot-mapping.
Fig. 6 shows a case where the locations of the ulcers
were not compatible with the angiosome model, but were
compatible with the StO2 foot-mapping.
DISCUSSION
The ‘StO2 foot-mapping’ by near-infrared spectroscopy
The near-infrared tissue oximeter monitor, OXY-2, can
rapidly and non-invasively measure many points of StO2.
Based on these features of StO2 measurement, foot-
mapping can be prepared and blood ﬂow evaluation of
the entire CLI patient’s foot is possible. The technique has
generally been called near-infrared spectroscopy (NIRS),
and was ﬁrst reported by Jöbsis.6 Various experimental and
clinical studies about NIRS have since been reported, and it
is believed that the StO2 measured by NIRS is an indicator
that closely reﬂects the peripheral blood ﬂow.7e12 In this
study, the boundary StO2 values of foot-mapping were set
to 30%, 50%, and 70%, taking into consideration past re-
ports12e14 and the ease of measuring.
From the results of StO2 foot-mapping, the StO2 value of
the CLI group was clearly lower than that of the control
Figure 5. Case 1 (The locations of ulcers were compatible with the angiosome model, and were also compatible with the StO2 foot-
mapping). This case had ulcers on the heel, on the lateral side of the ankle and on the second, third, and ﬁfth toes. The locations of
the ulcers are shown by arrows. The angiography study showed a relatively good anterior tibial artery ﬂow, but the ﬂow was directed
toward the plantar side via the perforator in the metatarsal region. The calcaneal branch of the PTA and the peroneal artery were both
occluded, which explains the ischemic ulcers on the heel. The lateral plantar artery was occluded, which explains the digital ischemic ulcers.
Hence, the distribution of the ulcers is compatible with the angiosome model. The ischemic ulcers were seen mostly in the low StO2 area,
so the locations of ulcers and StO2 foot-mapping were compatible. The high StO2 area was considered to be around the subcutaneous
branch ﬂow of the plantar aspect via the perforator from the dorsal to the plantar side, so that a correlation was seen between StO2 foot-
mapping and the results of the angiographic study.
438 Y. Kagaya et al.group, and almost all StO2 values of the control group were
above 50% (Fig. 4). Even though the control group was not
age and sex matched for the CLI group in this study, a clear
difference was observed in the StO2 values between the
two groups, indicating that the areas with a low StO2 value
(under 50%) indicate the ischemic areas of CLI patients’
feet.
Comparison of the StO2 foot-mapping with the angiosome
model. StO2 foot-mapping is considered to be able to
detect the ischemic areas in CLI patients’ feet more
appropriately than the angiosome model, based on the
results of this study. The distribution of ischemic and non-
ischemic areas in CLI patients’ feet noted by StO2 foot-
mapping was complex and different from the angiosome
model, suggesting that peripheral tissue perfusion in a CLI
patient’s foot is determined by the branch, capillary, and
microvascular blood ﬂow more than by the ﬁve or six areas
where the main arteries are supposed to feed separately, as
proposed under the angiosome concept.
The angiosome model connects the main arteries to
peripheral tissue, and has been considered useful for pre-
dicting the peripheral tissue perfusion by angiography.
However, it is possible that the angiosome model cannotexplain the actual distribution of peripheral tissue perfu-
sion, especially in cases of severe CLI. Since in such cases
the blood ﬂow toward the peripheral tissue is complicated
by such factors as the growth of collateral arteries, the di-
versity and atrophy of the capillary and microvascular
plexus, and other abnormalities of the vessels or peripheral
tissue, that peripheral tissue perfusion may not be related
to the main arterial blood ﬂow.
Comparison of StO2 foot-mapping with the other methods
used to evaluate the peripheral tissue perfusion. In order
to understand the actual blood supply to the peripheral
tissue in a CLI patient’s foot, an evaluation of the peripheral
tissue itself is considered to be necessary, but there have
been limited methods available for this purpose. Trans-
cutaneous oxygen tension (tcPO2)
15e19 and skin perfusion
pressure (SPP),15,16,18,20e25 have been used to indirectly and
non-invasively evaluate the arterial blood supply to the
peripheral tissue of CLI patients’ feet, and to detect
ischemia.
These methods evaluate only a few points, because it
takes a lot of time to evaluate each point, and because the
measurements are easily affected by the patient’s motion
and other factors. Sometimes a patient is unable to stand
Figure 6. Case 2 (the locations of ulcers were not compatible with the angiosome model, but were compatible with the StO2 foot-
mapping). This case had an ulcer comprising the entire ﬁrst toe, for which debridement was performed, because the ulcer had an
accompanying infection. Ulcers of the lateral heel region were also seen. The locations of ulcers are shown by arrows. The angiography
study showed a relatively good ﬂow of the three branches of the posterior tibial artery (PTA) and occlusions of the anterior tibial artery
(ATA) and the peroneal artery. The ischemic ulcers of the lateral heel are explained by peroneal artery occlusion. The ulcer of the ﬁrst toe
corresponds to the occlusions of the dorsalis pedis artery, medial plantar artery, and lateral plantar artery from the angiosome model;
however, the medial and lateral plantar arteries were patent on the basis of the angiography study. Hence, the distribution of the ulcers is
not compatible with the angiosome model. The ulcers were seen mostly in low StO2 areas, so the locations of ulcers and StO2 foot-mapping
results were compatible. High StO2 areas were mainly on the plantar aspect, and angiography showed that there was PTA-dominant blood
ﬂow. In addition, the partial high StO2 area of the distal dorsal aspect was considered to be around the perforator from the plantar to the
dorsal side. Therefore, a correlation was seen between the StO2 foot-mapping results and the results of angiography.
European Journal of Vascular and Endovascular Surgery Volume 47 Issue 4 p. 433e441 April/2014 439still during the measurement, and taking a measurement is
then impossible.
StO2 measurement is totally non-invasive and requires a
very short time for the evaluation of each point, so mea-
surement is possible even if a patient cannot stand still for a
long time. Although a direct comparison between StO2 foot-
mapping and tcPO2 or SPP is impossible, in terms of being
able to evaluate multiple points and the two-dimensional
distribution of the ischemic region in a short time, and
also the high success rate of performing a measurement
itself, StO2 foot-mapping can be said to be superior to tcPO2
or SPP.
The concept of the “real angiosome”. This study indicates
that StO2 foot-mapping can non-invasively evaluate from
the peripheral tissue the actual blood ﬂow in the entire foot
of a CLI patient, and can detect the ischemic areas which
cannot be determined by the angiosome concept.
We advocate the concept of the real angiosome: the
real distribution of peripheral tissue perfusion in a CLI
patient’s foot, which is determined by peripheral micro-
vascular blood ﬂow (Fig. 7). StO2 foot-mapping can detect
the real angiosome, which can locate the ischemic area in
a CLI patient’s foot more appropriately than the angio-
some concept. The difference between the two methods isconsidered to be because the real angiosome assessment
is based on the peripheral tissue, while the angiosome
assessment is based on the main arterial blood ﬂow of the
foot region.
The near-infrared tissue oximeter monitor, the OXY-2, can
evaluate the StO2 of peripheral tissue within 10 mm of the
skin surface, so the subcutaneous blood ﬂow is considered
to be related to StO2 foot-mapping, that is the real angio-
some. In most cases, a correlation was seen between StO2
foot-mapping and angiography results because the high
StO2 areas in the StO2 foot-mapping tended to follow the
subcutaneous main, branch, and capillary blood ﬂow in the
angiographies (Figs. 5 and 6), but that was not true for all
cases.
The peripheral tissue is directly fed by microvascular
blood ﬂow, which cannot be visualized by angiography but
is most likely distributed around the subcutaneous visual-
ized blood ﬂow. However, in some cases microvascular
blood ﬂow is considered to be independent of the visual-
ized blood ﬂow, and in other cases the microvascular plexus
is considered to be atrophic even if a visualized ﬂow is
present. This explains why the results of StO2 foot-mapping
sometimes did not agree with the subcutaneous visualized
blood ﬂow.
Figure 7. The concept of the “real angiosome”: the real distribution of the peripheral tissue perfusion in a CLI patient’s foot, which is
determined by the peripheral microvascular blood ﬂow. One block of the angiosome (medial plantar artery) model was picked for real
angiosome assessment, and the cross-section of the soft tissue in the block is shown. The main artery which feeds the angiosome runs
through and produces branches that spread subcutaneous capillary vessels and microvascular plexus to the cutis. Some branch arteries
diminish before reaching the subcutaneous soft tissue and the cutis. A collateral artery extends toward the skin surface area that is not fed
by the main artery, giving microvascular blood ﬂow to the peripheral tissue. A high StO2 area is seen around the region in which the
peripheral microvascular blood ﬂow exists, which cannot be visualized by angiography, and the area tends to be around the subcutaneous
capillary blood ﬂow that can be visualized by angiography. Both high and low StO2 areas are seen in the same angiosome, and a necrotic
region exists that could not be predicted from the angiographic observations, suggesting that the peripheral tissue perfusion in the CLI
patient’s foot was not determined by the main artery, but by the peripheral microvascular blood ﬂow.
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a vessel whose diameter is larger than 500 mm.26 A high-
resolution angiography system may successfully detect
thinner vessels in the foot,5 but not to the extent of
microvascular perfusion that directly feeds the peripheral
tissue. Recently, some experimental studies about quanti-
fying tissue perfusion of the foot using indocyanine green
angiography have been reported.27e29 It is possible that this
method can evaluate subcutaneous microvascular
perfusion.
The real angiosome assessment from StO2 foot-mapping
enabled us to easily image the ischemic and non-ischemic
regions. As a practical application of StO2 foot-mapping to
the clinical setting, StO2 foot-mapping can be used to detect
ischemic areas when performing appropriate debridement
or partial amputation, or to evaluate in which area and to
what degree peripheral tissue perfusion improves just after
revascularization therapy, adding a qualitative value to the
surgical and revascularization strategy for CLI. The evalua-
tion of peripheral tissue perfusion from StO2 foot-mapping
can inform the surgeon of a need for extra blood ﬂow
during or after revascularization therapy; however, further
investigations will be required to understand the changes of
StO2 in a CLI patient’s foot after revascularization therapyand for utilizing StO2 foot-mapping for the revascularization
strategy.
CONCLUSION
This study suggests that StO2 foot-mapping can successfully
and non-invasively detect ischemic areas in peripheral tis-
sue in the feet of CLI patients, and more appropriately than
assessment using the angiosome model. StO2 foot-mapping
can be used to evaluate the real angiosome: the real dis-
tribution of peripheral tissue perfusion in a CLI patient’s
foot, which is determined by the peripheral microvascular
blood ﬂow, rather than the main arterial blood ﬂow.
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